APOB and Mental deterioration: Intervention studies involving lipid-lowering treatments, such as statins, which is considered as the first-line treatment for lowering ApoB level, have not yielded sufficient evidence from clinical trials in favour of its therapeutic benefits in preventing cognitive decline or dementia.25